(Q45114054)

English

Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells

scientific article published in January 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

arsenic trioxide

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Xinquan Li

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Xianzhong Ding

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Thomas E Adrian

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

389-400

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Introduction: the history of arsenic trioxide in cancer therapy.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Risk/benefit profile of arsenic trioxide

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

History of the development of arsenic derivatives in cancer therapy

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Arsenic trioxide: an emerging therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

NR8383 alveolar macrophage toxic growth arrest by hydrogen peroxide is associated with induction of growth-arrest and DNA damage-inducible genes GADD45 and GADD153.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Induction of growth arrest and DNA damage-inducible genes Gadd45 and Gadd153 in primary rodent embryonic cells following exposure to methylmercury.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-200029068

21 January 2018

Identifiers

10.1081/CNV-200029068

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45114054&oldid=2066278378"